On April 20, 2023, Sirona Biochem Corp. closed the transaction. The company issued 1,563 unsecured convertible debentures units at a price of CAD 1,000 per debenture unit for aggregate gross proceeds of up to CAD 1,563,600 in an oversubscribed round of funding.

Howard Verrico, CEO of the company, subscribed to CAD 500,000 of Debenture Units.